Skip to main content
SpringerLink
Log in

Multipharmacy on the Older Adult

  • Chapter
  • First Online:
The Very Old Critically Ill Patients

Part of the book series: Lessons from the ICU ((LEICU))

  • 781 Accesses

Abstract

The use of medications in the elderly is a complex issue influenced by many health- and non-health-related factors. Drug therapy is one of the most important tools available for preserving and improving health. However, polypharmacy and the inappropriate use of medications can imply adverse effects and situations of vulnerability that trigger many negative health outcomes: reduced adherence, increased risk of hospitalization, nursing home admissions, adverse drug events (ADEs), emergency department (ED) visits, poor quality of life, and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017; https://doi.org/10.1186/s12877-017-0621-2.

  2. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345–51.

    Article  PubMed  Google Scholar 

  3. Rochon PA, Gurwitz JH. The prescribing cascade revisited. Lancet. 2017;389:1778–80.

    Article  PubMed  Google Scholar 

  4. Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32:113–21.

    Article  CAS  PubMed  Google Scholar 

  5. Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. Br Med J. 1997;315:1096–9.

    Article  CAS  Google Scholar 

  6. Morin L, Johnell K, Laroche ML, Fastbom J, Wastesson JW. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;10:289–98.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA - J Am Med Assoc. 2015;314:1818–31.

    Article  CAS  Google Scholar 

  8. Blozik E, Rapold R, Von Overbeck J, Reich O. Polypharmacy and potentially inappropriate medication in the adult, community-dwelling population in Switzerland. Drugs Aging. 2013;30:561–8.

    Article  CAS  PubMed  Google Scholar 

  9. Midão L, Giardini A, Menditto E, Kardas P, Costa E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr. 2018;78:213–20.

    Article  PubMed  Google Scholar 

  10. Ellenbogen MI, Wang P, Overton HN, Fahim C, Park A, Bruhn WE, Carnahan JL, Linsky AM, Balogun SA, Makary MA. Frequency and predictors of polypharmacy in US Medicare patients: a cross-sectional analysis at the patient and physician levels. Drugs Aging. 2020;37:57–65.

    Article  PubMed  Google Scholar 

  11. Wastesson JW, Morin L, Laroche ML, Johnell K. How chronic is polypharmacy in old age? A longitudinal Nationwide cohort study. J Am Geriatr Soc. 2019;67:455–62.

    Article  PubMed  Google Scholar 

  12. Gallagher P, Lang PO, Cherubini A, et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol. 2011;67:1175–88.

    Article  PubMed  Google Scholar 

  13. Jokanovic N, Tan ECK, Dooley MJ, Kirkpatrick CM, Bell JS. Prevalence and factors associated with polypharmacy in Long-term care facilities: a systematic review. J Am Med Dir Assoc. 2015;16:535.e1–12.

    Google Scholar 

  14. Rolland Y, Abellan Van Kan G, Hermabessiere S, Gerard S, Guyonnet-Gillette S, Vellas B. Descriptive study of nursing home residents from the REHPA network. J Nutr Heal Aging. 2009;13:679–83.

    Article  CAS  Google Scholar 

  15. Gutiérrez-Valencia M, Izquierdo M, Lacalle-Fabo E, Marín-Epelde I, Ramón-Espinoza MF, Domene-Domene T, Casas-Herrero Á, Galbete A, Martínez-Velilla N. Relationship between frailty, polypharmacy, and underprescription in older adults living in nursing homes. Eur J Clin Pharmacol. 2018;74:961–70.

    Article  PubMed  Google Scholar 

  16. Tosato M, Landi F, Martone AM, Cherubini A, Corsonello A, Volpato S, Bernabei R, Onder G. Potentially inappropriate drug use among hospitalised older adults: results from the CRIME study. Age Ageing. 2014;43:767–73.

    Article  PubMed  Google Scholar 

  17. Rashrash M, Schommer JC, Brown LM. Prevalence and predictors of herbal medicine use among adults in the United States. J Patient Exp. 2017;4:108–13.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Fu AZ, Jiang JZ, Reeves JH, Fincham JE, Liu GG, Perri M. Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Med Care. 2007;45:472–6.

    Article  PubMed  Google Scholar 

  19. Corsonello A, Pedone C, Incalzi R. Age-related pharmacokinetic and Pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem. 2010;17:571–84.

    Article  CAS  PubMed  Google Scholar 

  20. Hulka BS, Kupper LL, Cassel JC, Efird RL, Burdette JA. Medication use and misuse: physician-patient discrepancies. J Chronic Dis. 1975;28:7–21.

    Article  CAS  PubMed  Google Scholar 

  21. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13:57–65.

    Article  PubMed  Google Scholar 

  22. Cabré M, Elias L, Garcia M, Palomera E, Serra-Prat M. Avoidable hospitalizations due to adverse drug reactions in an acute geriatric unit. Analysis of 3,292 patients. Med Clin (Barc). 2018;150:209–14.

    Article  Google Scholar 

  23. Hill-Taylor B, Sketris I, Hayden J, Byrne S, O’Sullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38:360–72.

    Article  CAS  PubMed  Google Scholar 

  24. Pérez T, Moriarty F, Wallace E, McDowell R, Redmond P, Fahey T. Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study. BMJ. 2018; https://doi.org/10.1136/bmj.k4524.

  25. Hamilton H, Gallagher P, Ryan C, Byrne S, O’Mahony D. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011;171:1013–9.

    Article  PubMed  Google Scholar 

  26. Leelakanok N, Holcombe AL, Lund BC, Gu X, Schweizer ML. Association between polypharmacy and death: a systematic review and meta-analysis. J Am Pharm Assoc. 2017;57:729–38.e10.

    Google Scholar 

  27. Campins L, Serra-Prat M, Palomera E, Bolibar I, Martínez MÀ, Gallo P. Reduction of pharmaceutical expenditure by a drug appropriateness intervention in polymedicated elderly subjects in Catalonia (Spain). Gac Sanit. 2019;33:106–11.

    Article  PubMed  Google Scholar 

  28. Medication Safety in Polypharmacy. Geneva: World Health Organization; 2019 (WHO/UHC/SDS/2019.11). Licence: CC BY-NC-SA 3.0 IG.

    Google Scholar 

  29. Hovstadius B, Petersson G. Factors leading to excessive polypharmacy. Clin Geriatr Med. 2012;28:159–72.

    Article  PubMed  Google Scholar 

  30. Herr M, Sirven N, Grondin H, Pichetti S, Sermet C. Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population. Eur J Clin Pharmacol. 2017;73:1165–72.

    Article  PubMed  Google Scholar 

  31. Moulis F, Moulis G, Balardy L, et al. Exposure to atropinic drugs and frailty status. J Am Med Dir Assoc. 2015;16:253–7.

    Article  PubMed  Google Scholar 

  32. Jamsen KM, Bell JS, Hilmer SN, et al. Effects of changes in number of medications and drug burden index exposure on transitions between frailty states and death: the Concord health and ageing in men project cohort study. J Am Geriatr Soc. 2016;64:89–95.

    Article  PubMed  Google Scholar 

  33. Ruxton K, Woodman RJ, Mangoni AA. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis. Br J Clin Pharmacol. 2015;80:209–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Salahudeen MS, Hilmer SN, Nishtala PS. Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. J Am Geriatr Soc. 2015;63:85–90.

    Article  PubMed  Google Scholar 

  35. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. In: Lancet. Lancet Publishing Group; 2013. p. 752–62.

    Google Scholar 

  36. Gutiérrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero IM, Martínez-Velilla N. The relationship between frailty and polypharmacy in older people: a systematic review. Br J Clin Pharmacol. 2018;84:1432–44.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Palmer K, Villani ER, Vetrano DL, et al. Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis. Eur Geriatr Med. 2019;10:9–36.

    Article  PubMed  Google Scholar 

  38. Cullinan S, O’Mahony D, O’Sullivan D, Byrne S. Use of a frailty index to identify potentially inappropriate prescribing and adverse drug reaction risks in older patients. Age Ageing. 2016;45:115–20.

    Article  PubMed  Google Scholar 

  39. Muhlack DC, Hoppe LK, Stock C, Haefeli WE, Brenner H, Schöttker B. The associations of geriatric syndromes and other patient characteristics with the current and future use of potentially inappropriate medications in a large cohort study. Eur J Clin Pharmacol. 2018;74:1633–44.

    Article  CAS  PubMed  Google Scholar 

  40. Meid AD, Quinzler R, Freigofas J, Saum KU, Schöttker B, Holleczek B, Heider D, König HH, Brenner H, Haefeli WE. Medication underuse in aging outpatients with cardiovascular disease: prevalence, determinants, and outcomes in a prospective cohort study. PLoS One. 2015; https://doi.org/10.1371/journal.pone.0136339.

  41. Martinot P, Landré B, Zins M, Goldberg M, Ankri J, Herr M. Association between potentially inappropriate medications and frailty in the early old age: a longitudinal study in the GAZEL cohort. J Am Med Dir Assoc. 2018;19:967–73.e3.

    Google Scholar 

  42. Bandeen-Roche K, Seplaki CL, Huang J, Buta B, Kalyani RR, Varadhan R, Xue QL, Walston JD, Kasper JD. Frailty in older adults: a nationally representative profile in the United States. Journals Gerontol - Ser A Biol Sci Med Sci. 2015;70:1427–34.

    Article  Google Scholar 

  43. Porter B, Arthur A, Savva GM. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study. BMJ Open. 2019; https://doi.org/10.1136/bmjopen-2018-026171.

  44. Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166:605–9.

    Article  PubMed  Google Scholar 

  45. Morin L, Vetrano DL, Rizzuto D, Calderón-Larrañaga A, Fastbom J, Johnell K. Choosing wisely? Measuring the burden of medications in older adults near the end of life: Nationwide, longitudinal cohort study. Am J Med. 2017;130:927–36.e9.

    Google Scholar 

  46. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370:173–84.

    Article  PubMed  Google Scholar 

  47. Fick DM, Semla TP, Steinman M, et al. American Geriatrics Society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674–94.

    Article  Google Scholar 

  48. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8.

    Google Scholar 

  49. Lavan AH, Gallagher P, Parsons C, O’Mahony D. STOPPFrail (screening tool of older persons prescriptions in frail adults with limited life expectancy): consensus validation. Age Ageing. 2017;46:600–7.

    Article  PubMed  Google Scholar 

  50. Curtin D, Gallagher P, O’Mahony D. Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2. Age Ageing. 2020; https://doi.org/10.1093/ageing/afaa159.

  51. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, Cohen HJ, Feussner JR. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045–51.

    Article  CAS  PubMed  Google Scholar 

  52. Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of “deprescribing” with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80:1254–68.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175:827–34.

    Article  PubMed  Google Scholar 

  54. Jansen J, Naganathan V, Carter SM, et al. Too much medicine in older people? Deprescribing through shared decision making. BMJ. 2016; https://doi.org/10.1136/bmj.i2893.

  55. Monteiro L, Maricoto T, Solha I, Ribeiro-Vaz I, Martins C, Monteiro-Soares M. Reducing potentially inappropriate prescriptions for older patients using computerized decision support tools: systematic review. J Med Internet Res. 2019; https://doi.org/10.2196/15385.

  56. Anderson LJ, Schnipper JL, Nuckols TK, Shane R, Sarkisian C, Le MM, Pevnick JM, Hughes CM, Jackevicius CA, O’Mahony D. A systematic overview of systematic reviews evaluating interventions addressing polypharmacy. Am J Heal Pharm. 2019;76:1777–87.

    Article  Google Scholar 

  57. Bloomfield HE, Greer N, Linsky AM, Bolduc J, Naidl T, Vardeny O, MacDonald R, McKenzie L, Wilt TJ. Deprescribing for community-dwelling older adults: a systematic review and meta-analysis. J Gen Intern Med. 2020; https://doi.org/10.1007/s11606-020-06089-2.

  58. Shrestha S, Poudel A, Steadman K, Nissen L. Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: a systematic review. Br J Clin Pharmacol. 2020;86:1931–45.

    Article  PubMed  Google Scholar 

  59. Doherty AJ, Boland P, Reed J, Clegg AJ, Stephani AM, Williams NH, Shaw B, Hedgecoe L, Hill R, Walker L. Barriers and facilitators to deprescribing in primary care: a systematic review. BJGP Open. 2020; https://doi.org/10.3399/bjgpopen20X101096.

  60. Van Der Linden L, Hias J, Dreessen L, Milisen K, Flamaing J, Spriet I, Tournoy J. Medication review versus usual care to improve drug therapies in older inpatients not admitted to geriatric wards: a quasi-experimental study (RASP-IGCT). BMC Geriatr. 2018; https://doi.org/10.1186/s12877-018-0843-y.

  61. Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, Kettis-Lindblad Å, Melhus H, Mörlin C. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169:894–900.

    Article  PubMed  Google Scholar 

  62. Lehnbom EC, Stewart MJ, Manias E, Westbrook JI. Impact of medication reconciliation and review on clinical outcomes. Ann Pharmacother. 2014;48:1298–312.

    Article  PubMed  Google Scholar 

  63. Anderson LJ, Schnipper JL, Nuckols TK, et al. Effect of medication reconciliation interventions on outcomes: a systematic overview of systematic reviews. Am J Heal Pharm. 2019;76:2028–40.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Complejo Hospitalario de Navarra, Department of Geriatric Medicine, Pamplona, Spain

    Lozano Vicario Lucía

  2. Servicio Navarro de Salud, Sección de Innovación y Organización, Pamplona, Spain

    Gutiérrez-Valencia Marta

  3. Complejo Hospitalario de Navarra, Department of Geriatric Medicine – Navarrabiomed, Pamplona, Spain

    Martínez-Velilla Nicolas

Authors
  1. Lozano Vicario Lucía
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gutiérrez-Valencia Marta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martínez-Velilla Nicolas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martínez-Velilla Nicolas .

Editor information

Editors and Affiliations

  1. Faculty of Medicine, Department of Clinical Medicine and Department of Anaesthesia and Intensive Care, University of Bergen and Haukeland University Hospital, Bergen, Norway

    Hans Flaatten

  2. Sorbonne Université, INSERM Institut Pierre Louis d’Epidémiologie et de, Santé Publique, AP-HP, Hôpital Saint Antoine, Paris, France

    Bertrand Guidet

  3. Sorbonne Université, Hôpital Saint Antoine Unité de Gériatrie Aiguë, Assistance Publique, Hôpitaux de Paris, Paris, France

    Hélène Vallet

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lucía, L.V., Marta, GV., Nicolas, MV. (2022). Multipharmacy on the Older Adult. In: Flaatten, H., Guidet, B., Vallet, H. (eds) The Very Old Critically Ill Patients. Lessons from the ICU. Springer, Cham. https://doi.org/10.1007/978-3-030-94133-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-94133-8_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-94132-1

  • Online ISBN: 978-3-030-94133-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation